Related Experiment Video
Updated: Jul 30, 2026
12:27
Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50.
Sugunya Utaida1, Richard F Pfeltz, R K Jayaswal
1Microbiology Group, Department of Biological Sciences, 210 Julian Hall, Illinois State University, Normal, Illinois 61790-4120, USA.
Antimicrobial Agents and Chemotherapy
|March 30, 2006
Summary
Whole-cell autolytic activity in glycopeptide-intermediate Staphylococcus aureus (GISA) was reduced. However, autolysin activity against cell walls was high, indicating complex regulation in GISA strains.
Area of Science:
- Microbiology
- Bacterial cell wall biology
- Antimicrobial resistance
Background:
- Glycopeptide-intermediate Staphylococcus aureus (GISA) poses a significant threat due to reduced susceptibility to vancomycin.
- Autolytic activity, crucial for cell wall remodeling, is implicated in bacterial physiology and antibiotic resistance.
- Understanding autolysis regulation in GISA is vital for developing new therapeutic strategies.
Purpose of the Study:
- To investigate and compare the whole-cell autolytic activity of a prototypical GISA strain (Mu50) with hetero-GISA (Mu3) and susceptible strains.
- To explore the autolytic activity of GISA crude cell walls and autolysin extracts against purified cell walls.
Main Methods:
- Comparative analysis of whole-cell autolytic activity.
- Enzymatic assays using crude cell walls and autolysin extracts from GISA strains.
- Assessment of autolytic activity against purified bacterial cell walls.
Main Results:
- Whole-cell autolytic activity was reduced in the prototypical GISA Mu50 strain compared to hetero-GISA Mu3 and susceptible S. aureus.
- Autolytic activity of Mu50 crude cell walls and autolysin extracts against purified cell walls was relatively high.
- Findings suggest complex regulatory mechanisms governing autolysis in GISA.
Conclusions:
- GISA strains exhibit reduced overall autolytic activity, aligning with previous observations.
- Specific components like crude cell walls and autolysin extracts from GISA show significant autolytic potential, highlighting intricate regulatory processes.
- Further research into GISA autolysis regulation is warranted to understand its role in pathogenesis and resistance.
More Related Videos
Related Concept Videos
01:28Peptidoglycan Synthesis
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...